202 Endoscopic variceal band ligation in comparison with propranolol in prophylaxis of first variceal bleeding in patients with liver cirrhosis. Journal of Hepatology. 2005;42(Suppl.1):79.

Review Manager (RevMan) [Computer program]. Version 5. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2015. Available from: http://tech​.cochrane.org/Revman.

WinBUGS [Computer programme] version 1.4. Cambridge: MRC Biostatistics Unit, University of Cambridge; 2015. Available from: http://www​.mrc-bsu.cam​.ac.uk/software/bugs​/the-bugs-project-winbugs/

Abdelfattah MH, Rashed MA, Elfakhry AA, Soliman MA, Shiha GE. 201 Endoscopic variceal ligation versus pharmacologic treatment for primary prophylaxis of variceal bleeding: a randomised study. Journal of Hepatology. 2006;44(Suppl.1):S83.

Abid S, Jafri W, Mumtaz K, Islam M, Abbas Z, Shah HA, et al. Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy. Journal of the College of Physicians and Surgeons--Pakistan. 2011;21(11):666–671. [PubMed: 22078345]

Abulfutuh AR, Morsy M, Solyman AEG, Hendawy SE, Desouky ME, Hadad SE, et al. Study of variceal band ligation, propranolol and isosorbide mononitrate in the prevention of the first variceal bleeding. Gastroenterology. 2003;124(4):A780.

Ahmad I, Khan AA, Alam A, Dilshad A, Butt AK, Shafqat F, et al. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. Journal of the College of Physicians and Surgeons--Pakistan. 2008;18(11):684–687. [PubMed: 18983791]

Andreani T, Poupon R, Balkau BJ, Trinchet JC, Grange JD, Peigney N, et al. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology. 1990;12(6):1413–1419. [PubMed: 2258157]

Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, et al. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PloS One. 2013;8(9):e72904. [PMC free article: PMC3781134] [PubMed: 24086266]

Arena U, Vizzutti F, Abraldes JG, Corti G, Stasi C, Moscarella S, et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut. 2008;57(9):1288–1293. [PubMed: 18448567]

Arroyo V, Guevara M, Gines P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology. 2002;122(6):1658–1676. [PubMed: 12016430]

Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(4):1246–1256. [PubMed: 20558165]

Askgaard G, Gronbaek M, Kjaer MS, Tjonneland A, Tolstrup JS. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. Journal of Hepatology. 2015;62(5):1061–1067. [PubMed: 25634330]

Aykut UE, Akyuz U, Yesil A, Eren F, Gerin F, Ergelen R, et al. A comparison of FibroMeter NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology. 2014;49(11):1343–1348. [PubMed: 25259621]

Becker U, Gronbaek M, Johansen D, Sorensen TIA. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology. 2002;35(4):868–875. [PubMed: 11915033]

Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6):1449–1457. [PubMed: 14647056]

Bendtsen F, Skovgaard LT, Sorensen TI, Matzen P. Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding. Hepatology. 1990;11(3):341–347. [PubMed: 2312048]

Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut. 2004;53(5):744–749. [PMC free article: PMC1774055] [PubMed: 15082595]

Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108(6):1828–1834. [PubMed: 7768389]

Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55(4):1172–1181. [PubMed: 22095893]

Blackwelder WC, Yano K, Rhoads GG, Kagan A, Gordon T, Palesch Y. Alcohol and mortality: the Honolulu Heart Study. American Journal of Medicine. 1980;68(2):164–169. [PubMed: 7355889]

Borroni G, Ceriani R, Cazzaniga M, Tommasini M, Roncalli M, Maltempo C, et al. Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C. Alimentary Pharmacology and Therapeutics. 2006;24(5):797–804. [PubMed: 16918883]

Bota S, Sirli R, Sporea I, Focsa M, Popescu A, Danila M, et al. A new scoring system for prediction of fibrosis in chronic hepatitis C. Hepatitis Monthly. 2011;11(7):548–555. [PMC free article: PMC3212757] [PubMed: 22087193]

Bota S, Sporea I, Sirli R, Popescu A, Gradinaru-Tascau O. How useful are ARFI elastography cut-off values proposed by meta-analysis for predicting the significant fibrosis and compensated liver cirrhosis? Medical Ultrasonography. 2015;17(2):200–205. [PubMed: 26052571]

Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32(3):477–481. [PubMed: 10960438]

Cales P, Zabotto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H, et al. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology. 1990;98(1):156–162. [PubMed: 2293575]

Canavan C, Eisenburg J, Meng L, Corey K, Hur C. Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK. Digestive Diseases and Sciences. 2013;58(9):2691–2704. [PMC free article: PMC4067701] [PubMed: 23720196]

Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652–659. [PubMed: 15349904]

Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver International. 2012;32(4):612–621. [PubMed: 22103765]

Castera L, Sebastiani G, Le Bail B, de Ledinghen V, Couzigou P, Alberti A. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. Journal of Hepatology. 2010;52(2):191–198. [PubMed: 20006397]

Catanzaro R, Milazzo M, Arona S, Sapienza C, Vasta D, Arcoria D, et al. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C. Hepatobiliary and Pancreatic Diseases International. 2013;12(5):500–507. [PubMed: 24103280]

Caviglia GP, Ciancio A, Rosso C, Abate ML, Olivero A, Pellicano R, et al. Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment. Annals of Hepatology. 2013;13(1):91–97. [PubMed: 24378271]

Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, et al. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. Journal of Parenteral and Enteral Nutrition. 1985;9(3):288–295. [PubMed: 3892073]

Cerra FB, McMillen M, Angelico R, Cline B, Lyons J, Faulkenbach L, et al. Cirrhosis, encephalopathy, and improved results with metabolic support. Surgery. 1983;94(4):612–619. [PubMed: 6623361]

Chasalani N, Imperiale TF, Ismail A, Carey M, Wilcox CM, Madichetty H, et al. Predictors of large esophageal varices in patients with cirrhosis. American Journal of Gastroenterology. 1999;94(11):3285–3291. [PubMed: 10566731]

Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, Mendez-Sanchez N, Gluud C, et al. Meta-analysis: Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - An updated Cochrane review. Alimentary Pharmacology and Therapeutics. 2011;34(5):509–518. [PubMed: 21707680]

Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews. 2010;(9) CD002907. [PMC free article: PMC7138054] [PubMed: 20824832] [CrossRef]

Chen CY, Sheu MZ, Su SY. Prophylactic endoscopic variceal ligation (EVL) with multiple band ligator for esophageal varices. Gastroenterology. 1998;114(Suppl.1):A1224.

Chen SH, Li YF, Lai HC, Kao JT, Peng CY, Chuang PH, et al. Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C. BMC Gastroenterology. 2012;12:105. [PMC free article: PMC3462151] [PubMed: 22877310]

Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, et al. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. European Journal of Gastroenterology and Hepatology. 2006;18(4):389–396. [PubMed: 16538110]

Cohen MJ, Sahar T, Benenson S, Elinav E, Brezis M, Soares-Weiser K. Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding. Cochrane Database of Systematic Reviews. 2009;(2) CD004791. [PubMed: 19370611] [CrossRef]

Conn HO, Grace N, Bosch J, Groszmann R, Rodes J, Wright SC, et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. Hepatology. 1991;13(5):902–912. [PubMed: 2029994]

Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodriguez-Peralvarez M, et al. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technology Assessment. 2015;19(9):1–410. [PMC free article: PMC4781028] [PubMed: 25633908]

Cucchetti A, Trevisani F, Cescon M, Ercolani G, Farinati F, Poggio PD, et al. Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. Journal of Hepatology. 2012;56(5):1089–1096. [PubMed: 22245900]

Cucchetti A, Trevisani F, Pecorelli A, Erroi V, Farinati F, Ciccarese F, et al. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. Journal of Hepatology. 2014;61(2):333–341. [PubMed: 24717522]

D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Seminars in Liver Disease. 1999;19(4):475–505. [PubMed: 10643630]

D'Amico G, Luca A, Morabito A, Miraglia R, D'Amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129(4):1282–1293. [PubMed: 16230081]

D'Antiga L, Betalli P, de Angelis P, Davenport M, Di Giorgio A, McKiernan PJ, et al. Interobserver Agreement on Endoscopic Classification of Oesophageal Varices in Children. Journal of Pediatric Gastroenterology and Nutrition. 2015;61(2):176–181. [PubMed: 25883057]

Davies SC. Annual report of the Chief Medical Officer: On the State of the Public's Health. London: Department of Health; 2011.

de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology. 2005;43(1):167–176. [PubMed: 15925423]

de la Mora JG, Farca-Belsaguy AA, Uribe M, de Hoyos-Garza A. Ligation VS propranolol for primary prophilaxis of variceal bleeding using a multiple band liga-tor and objective measurements of treatment adequacy: Preliminary results. Gastroenterology. 2000;118(4):A1434–A1435.

de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. Journal of Acquired Immune Deficiency Syndromes. 2006;41(2):175–179. [PubMed: 16394849]

De BK, Ghoshal UC, Das T, Santra A, Biswas PK. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. Journal of Gastroenterology and Hepatology. 1999;14(3):220–224. [PubMed: 10197489]

Drastich P, Lata J, Petrtyl J, Bruha R, Prochazka V, Vanasek T, et al. Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding. Annals of Hepatology. 2011;10(2):142–149. [PubMed: 21502675]

Ebinuma H, Saito H, Komuta M, Ojiro K, Wakabayashi K, Usui S, et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan(^®). Journal of Gastroenterology. 2011;46(10):1238–1248. [PubMed: 21779759]

El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–2576. [PubMed: 17570226]

Esmat G, Elsharkawy A, El Akel W, Fouad A, Helal K, Mohamed MK, et al. Fibroscan of chronic HCV patients coinfected with schistosomiasis. Arab Journal of Gastroenterology. 2013;14(3):109–112. [PubMed: 24206738]

Fahmy MI, Badran HM. Comparison of transient elastography to Doppler indices in prediction of hepatitis C induced liver fibrosis and cirrhosis. Egyptian Journal of Radiology and Nuclear Medicine. 2011;42(2):111–117.

Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, et al. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology. 1999;29(6):1704–1707. [PubMed: 10347111]

Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–721. [PubMed: 11870389]

Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, et al. Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Hepatology. 2012;56(4):1439–1447. [PubMed: 22532296]

Fernandes FF, Ferraz ML, Andrade LE, Dellavance A, Terra C, Pereira G, et al. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients. Journal of Clinical Gastroenterology. 2015;49(3):235–241. [PubMed: 24714186]

Fernandez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551–1561. [PubMed: 22183941]

Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. Journal of Hepatology. 2012;56(Suppl.1):S1–12. [PubMed: 22300459]

Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140–148. [PubMed: 11786970]

Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007;133(3):818–824. [PubMed: 17854593]

Fernandez J, Ruiz del Arbol L, Gomez C, Durandez R, Serradilla R, Guarner C. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131(4):1049–1056. [PubMed: 17030175]

Fernandez J, Monteagudo J, Bargallo X, Jimenez W, Bosch J, Arroyo V, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42(3):627–634. [PubMed: 16108036]

Ferraioli G, Tinelli C, Dal Bello B, Zicchetti M, Filice G, Filice C, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012;56(6):2125–2133. [PubMed: 22767302]

Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G, et al. Point shear wave elastography method for assessing liver stiffness. World Journal of Gastroenterology. 2014;20(16):4787–4796. [PMC free article: PMC4000517] [PubMed: 24782633]

Fiaccadori F, Ghinelli F, Pedretti G, Pelosi G, Sacchini D, Zeneroli ML. Branched chain amino acid enriched solutions in the treatment of hepatic encephalopathy: a controlled trial. In: Capocaccia L, Fischer JE, Rossi-Fanelli F, editors. Hepatic encephalopathy in chronic liver failure. New York: Plenum Press; 1984. pp. 323–333.

Fierbinteanu Braticevici C, Sporea I, Panaitescu E, Tribus L. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound in Medicine and Biology. 2013;39(11):1942–1950. [PubMed: 23932277]

Fierbinteanu-Braticevici C, Andronescu D, Usvat R, Cretoiu D, Baicus C, Marinoschi G. Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis. World Journal of Gastroenterology. 2009;15(44):5525–5532. [PMC free article: PMC2785054] [PubMed: 19938190]

Finkenstedt A, Dorn L, Edlinger M, Prokop W, Risch L, Griesmacher A, et al. Cystatin C is a strong predictor of survival in patients with cirrhosis: Is a cystatin C-based MELD better? Liver International. 2012;32(8):1211–1216. [PubMed: 22380485]

Floreani A, Cazzagon N, Martines D, Cavalletto L, Baldo V, Chemello L. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Digestive and Liver Disease. 2011;43(11):887–892. [PubMed: 21783442]

Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology. 2002;36(5 Suppl 1):S57–S64. [PubMed: 12407577]

Friedrich-Rust M, Hadji-Hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. European Radiology. 2010;20(10):2390–2396. [PubMed: 20526777]

Friedrich-Rust M, Rosenberg W, Parkes J, Herrmann E, Zeuzem S, Sarrazin C. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterology. 2010;10:103. [PMC free article: PMC2944336] [PubMed: 20828377]

Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, et al. Alcohol consumption and mortality among women. New England Journal of Medicine. 1995;332(19):1245–1250. [PubMed: 7708067]

Fujii H, Enomoto M, Fukushima W, Ohfuji S, Mori M, Kobayashi S, et al. Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis. Journal of Gastroenterology. 2009;44(6):608–614. [PubMed: 19360373]

Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, et al. Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis. Journal of Hepatology. 2011;54(1):64–71. [PubMed: 20932598]

Gheorghe C, Gheorghe L, Vadan R, Hrehoret D, Popescu I. Prophylactic banding ligation of high risk esophageal varices inpatients on the waiting list for liver transplantation: an interim report. Journal of Hepatology. 2002;36(Suppl.1):38.

Giannini E, Arzani L, Borro P, Botta F, Fasoli A, Risso D, et al. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepato-Gastroenterology. 2000;47(35):1395–1398. [PubMed: 11100360]

Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987;93(2):234–241. [PubMed: 3297907]

Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7(1):122–128. [PubMed: 3804191]

Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12(4 Pt.1):716–724. [PubMed: 2210673]

Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123(6):1839–1847. [PubMed: 12454841]

Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database of Systematic Reviews. 2012;(8) CD004544. [PubMed: 22895942] [CrossRef]

Grace N. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. American Journal of Gastroenterology. 1997;92(7):1081–1091. [PubMed: 9219775]

Grace N, Groszmann R, Garcia-Tsao G, Burroughs A, Pagliaro L, Makuch R, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28(3):868–880. [PubMed: 9731585]

GRADE Working Group. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group website. 2011. [8 October 2015]. Available from: http://www​.gradeworkinggroup.org/

Grange JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. Journal of Hepatology. 1998;29(3):430–436. [PubMed: 9764990]

Groszmann R, Bosch J, Grace N, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99(5):1401–1407. [PubMed: 2210246]

Guechot J, Trocme C, Renversez JC, Sturm N, Zarski JP., ANRS HC EP 23 Fibrostar Study Group. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C. Clinical Chemistry and Laboratory Medicine. 2012;50(4):693–699. [PubMed: 22505560]

Gyr K, Meier R, Haussler J, Bouletreau P, Fleig WE, Gatta A, et al. Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study. Gut. 1996;39(2):319–324. [PMC free article: PMC1383318] [PubMed: 8977350]

Halfon P, Bacq Y, de Muret A, Penaranda G, Bourliere M, Ouzan D, et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. Journal of Hepatology. 2007;46(3):395–402. [PubMed: 17156890]

Hassanein T, Tofteng F, Brown RS Jr., McGuire B, Lynch P, Mehta R, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007;46(6):1853–1862. [PubMed: 17975845]

Health & Social Care Information Centre. Provisional Monthly Hospital Episode Statistics for Admitted Patient Care, Outpatients and Accident and Emergency Data - April 2012 to December 2012. 2013. [20 October 2015]. Available from: http://www​.hscic.gov​.uk/catalogue/PUB10706.

Health & Social Care Information Centre. Count of finished admission episodes (FAEs) with a primary diagnosis of diseases of liver from 2005/06 to 2014/154, at England level. Hospital Episode Statistics. 2015. [20 October 2015]. Available from: http://www​.hscic.gov​.uk/media/18177/Liver-Diseases-2005-06-to-2014-15​/xls/Liver_Diseases​_2005-06_to_2014-15.xlsx.

Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology. 2001;33(4):802–807. [PubMed: 11283842]

Imperiale TF, Klein RW, Chalasani N. Cost-effectiveness analysis of variceal ligation vs beta-blockers for primary prevention of variceal bleeding. Hepatology. 2007;45(4):870–878. [PubMed: 17393528]

Ioannou GN, Perkins JD, Carithers RL. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology. 2008;134(5):1342–1351. [PubMed: 18471511]

Ioannou GN, Weiss NS, Kowdley K, Dominitz JA. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology. 2003;125(4):1053–1059. [PubMed: 14517789]

Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. Journal of Hepatology. 2014;60(6):1310–1324. [PubMed: 24530646]

Janssens F, de Suray N, Piessevaux H, Horsmans Y, de Timary P, Starkel P. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study. Journal of Clinical Gastroenterology. 2010;44(8):575–582. [PubMed: 20104185]

Jutabha R, Jensen DM, Martin P, Savides T, Han S, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology. 2005;128(4):870–881. [PubMed: 15825071]

Jutabha R, Jensen DM, Martin P, Savides TJ, Lam F, Jensen ME, et al. Initial report of a randomized, prospective study of prophylactic propranolol compared to rubber band ligation for prevention of first variceal hemorrhage in cirrhotics with large esophageal varices. Gastroenterology. 2000;118(4):A212–A213.

Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation. 2014;74(3):240–247. [PubMed: 24460024]

Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. Journal of Hepatology. 2007;46(4):628–634. [PubMed: 17258346]

Kim BI, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, et al. Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage. Journal of Gastroenterology and Hepatology. 2011;26(3):550–557. [PubMed: 21332551]

Kim BK, Park YN, Kim DY, Park JY, Chon CY, Han KH, et al. Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. Digestion. 2012;85(3):219–227. [PubMed: 22414567]

Kim MN, Kim SU, Park JY, Kim DY, Han KH, Chon CY, et al. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir. Journal of Clinical Gastroenterology. 2014;48(3):272–278. [PubMed: 23811938]

Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. American Journal of Epidemiology. 1992;136(10):1248–1257. [PubMed: 1476147]

Klibansky DA, Mehta SH, Curry M, Nasser I, Challies T, Afdhal N. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. Journal of Viral Hepatitis. 2012;19(2):e184–e193. [PubMed: 22239518]

Laccetti M, Manes G, Uomo G, Lioniello M, Rabitti PG, Balzano A. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study. Digestive and Liver Disease. 2000;32(4):335–338. [PubMed: 11515632]

Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41(6):1376–1382. [PubMed: 15915455]

Lay CS, Tsai YT, Lee FY, Lai YL, Yu CJ, Chen CB, et al. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. Journal of Gastroenterology and Hepatology. 2006;21(2):413–419. [PubMed: 16509867]

Lay CS, Tsai YT, Teg CY, Shyu WS, Guo WS, Wu KL, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology. 1997;25(6):1346–1350. [PubMed: 9185751]

Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. Journal of Hepatology. 1996;25(2):135–144. [PubMed: 8878773]

Leroy V, Sturm N, Faure P, Trocme C, Marlu A, Hilleret MN, et al. Prospective evaluation of FibroTest, FibroMeter, and HepaScore for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C. Journal of Hepatology. 2014;61(1):28–34. [PubMed: 24631902]

Liu B, Balkwill A, Reeves G, Beral V., Million Women Study Collaborators. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ. 2010;340:c912. [PMC free article: PMC2837146] [PubMed: 20223875]

Liu J, Jing Z-F, Yan J-H, Luo M, Hu R. Therapeutic effects of octreotide combined with alprostadil on cirrhosis with hepatorenal syndrome. World Chinese Journal of Digestology. 2014;22(14):2034–2038.

Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29(1):62–67. [PubMed: 9862851]

Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointestinal Endoscopy. 2004;59(3):333–338. [PubMed: 14997127]

Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI, Chiang HT. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. Journal of Hepatology. 1999;31(3):451–456. [PubMed: 10488703]

Loguercio C, Del Vecchio BC, Coltorti M. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study. Journal of International Medical Research. 1987;15(6):335–343. [PubMed: 3125077]

Lui HF, Stanley AJ, Forrest E, Jalan R, Hislop WS, Mills PR, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology. 2002;123(3):735–744. [PubMed: 12198700]

Lupsor Platon M, Stefanescu H, Feier D, Maniu A, Badea R. Performance of unidimensional transient elastography in staging chronic hepatitis C. Results from a cohort of 1,202 biopsied patients from one single center. Journal of Gastrointestinal and Liver Diseases. 2013;22(2):157–166. [PubMed: 23799214]

Lupsor M, Badea R, Stefanescu H, Sparchez Z, Branda H, Serban A, et al. Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. Journal of Gastrointestinal and Liver Diseases. 2009;18(3):303–310. [PubMed: 19795024]

Macias J, Giron-Gonzalez JA, Gonzalez-Serrano M, Merino D, Cano P, Mira JA, et al. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut. 2006;55(3):409–414. [PMC free article: PMC1856097] [PubMed: 16118349]

Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–871. [PubMed: 10733541]

Martinez SM, Fernandez-Varo G, Gonzalez P, Sampson E, Bruguera M, Navasa M, et al. Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Alimentary Pharmacology and Therapeutics. 2011;33(1):138–148. [PubMed: 21083589]

Mas A, Rodes J, Sunyer L, Rodrigo L, Planas R, Vargas V, et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. Journal of Hepatology. 2003;38(1):51–58. [PubMed: 12480560]

Merli M, Nicolini G, Angeloni S, Rinaldi V, De SA, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. Journal of Hepatology. 2003;38(3):266–272. [PubMed: 12586291]

Miquel M, Sopena J, Vergara M, Gil M, Casas M, Sanchez-Delgado J, et al. Factors related to survival in hepatocellular carcinoma in the geographic area of Sabadell (Catalonia, Spain). Revista Espanola De Enfermedades Digestivas. 2012;104(5):242–247. [PubMed: 22662776]

Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World Journal of Gastroenterology. 2010;16(8):966–972. [PMC free article: PMC2828601] [PubMed: 20180235]

Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine. 2012;367(20):1901–1911. [PubMed: 23075127]

Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012;55(1):199–208. [PubMed: 21898479]

Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. Journal of Gastroenterology. 2011;46(1):78–85. [PubMed: 20632194]

National Clinical Guideline Centre. Gastrointestinal bleeding: the management of acute upper gastrointestinal bleeding. London: National Clinical Guideline Centre; 2012. (NICE clinical guideline 141). Available from: http://guidance​.nice.org.uk/CG141.

National Clinical Guideline Centre. Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young people and adults. London: National Clinical Guideline Centre; 2013. (NICE clinical guideline 165). Available from: http://guidance​.nice.org.uk/CG165.

National Clinical Guideline Centre. Non-alcoholic fatty liver disease: assessment and management of non-alcoholic fatty liver disease (NAFLD) in adults, children and young people. London: National Clinical Guideline Centre; 2016. (NICE clinical guideline 49). Available from: http://www​.nice.org.uk/guidance/NG49.

National Institute for Health and Care Excellence. Developing NICE guidelines: the manual. London: National Institute for Health and Care Excellence; 2014. Available from: http://www​.nice.org.uk​/article/PMG20/chapter​/1%20Introduction%20and%20overview. [PubMed: 26677490]

National Institute for Health and Clinical Excellence. Social value judgements: principles for the development of NICE guidance. 2nd edition. London: National Institute for Health and Clinical Excellence; 2008. Available from: http://www​.nice.org.uk​/media/C18/30/SVJ2PUBLICATION2008.pdf. [PubMed: 27905706]

National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2012. Available from: http://publications​.nice​.org.uk/the-guidelines-manual-pmg6/ [PubMed: 27905714]

National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2013. 2nd edition. London: National Institute for Health and Clinical Excellence; 2013. Available from: http://publications​.nice.org.uk/pmg9. [PubMed: 27905712]

Ng FH, Wong SY, Loo CK, Lam KM, Lai CW, Cheng CS. Prediction of oesophagogastric varices in patients with liver cirrhosis. Journal of Gastroenterology and Hepatology. 1999;14(8):785–790. [PubMed: 10482429]

NHS Choices. Cirrhosis. 2012. [24 September 2015]. Available from: http://www​.nhs.uk/conditions​/cirrhosis/pages/introduction​.aspx.

Norberto L, Polese L, Cillo U, Grigoletto F, Burroughs A, Neri D, et al. A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transplantation. 2007;13(9):1272–1278. [PubMed: 17370331]

Novielli N, Cooper NJ, Abrams KR, Sutton AJ. How is evidence on test performance synthesized for economic decision models of diagnostic tests? A systematic appraisal of Health Technology Assessments in the UK since 1997. Value in Health. 2010;13(8):952–957. [PubMed: 21029247]

Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP). 2014. [15 January 2014]. Available from: http://www​.oecd.org/std/ppp.

Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las HD, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36(4 Pt 1):941–948. [PubMed: 12297842]

Pagliaro L, D'Amico G, Pasta L, Filippazzo G, Manenti F, Dobrilla G, et al. Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. Journal of Hepatology. 1989;9(1):75–83. [PubMed: 2671121]

Pagliaro L, D'Amico G, Pasta L, Filippazzo MG, Manenti F, Dobrilla G, et al. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: A multicenter, randomized clinical trial. Hepatology. 1988;8(1):1–5. [PubMed: 2892771]

Pagliaro L, Pasta L, D'Amico G. A randomised controlled trial of propranolol for the prevention of initial bleeding in cirrhotic patients with portal hypertension. Preliminary results. Drugs. 1989;37(Suppl.2):48–6. [PubMed: 2680431]

Paik YH, Lee KS, Han KH, Song KH, Kim MH, Moon BS, et al. Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study. Yonsei Medical Journal. 2005;46(3):399–407. [PMC free article: PMC2815818] [PubMed: 15988813]

Parker MJ, Guha N, Stedman B, Hacking N, Wright M. Trans-jugular intrahepatic porto-systemic shunt placement for refractory ascites: a ‘real-world’ UK health economic evaluation. Frontline Gastroenterology. 2013;4(3):182–186. [PMC free article: PMC5370052] [PubMed: 28839725]

Pascal JP, Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. New England Journal of Medicine. 1987;317(14):856–861. [PubMed: 3306385]

Pascal JP, Cales P. Propranolol in the primary prevention of upper gastrointestinal tract haemorrhage in patients with cirrhosis of the liver and oesophageal varices. Drugs. 1989;37(Suppl.2):52–56. [PubMed: 2680432]

Pascual S, Irurzun J, Zapater P, Such J, Sempere L, Carnicer F, et al. Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver International. 2008;28(5):682–689. [PubMed: 18433394]

Perez-Ayuso RM, Valderrama S, Espinoza M, Rollan A, Sanchez R, Otarola F, et al. Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices. Annals of Hepatology. 2010;9(1):15–22. [PubMed: 20308718]

Perez-Latorre L, Sanchez-Conde M, Rincon D, Miralles P, Aldamiz-Echevarria T, Carrero A, et al. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography. Clinical Infectious Diseases. 2014;58(5):713–718. [PubMed: 24265358]

Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine. 2012;367(2):124–134. [PubMed: 22738085]

Piscaglia F, Salvatore V, Di Donato R, D'Onofrio M, Gualandi S, Gallotti A, et al. Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography. Ultraschall in Der Medizin. 2011;32(2):167–175. [PubMed: 21321842]

Planas R, Montoliu S, Balleste B, Rivera M, Miquel M, Masnou H, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clinical Gastroenterology and Hepatology. 2006;4(11):1385–1394. [PubMed: 17081806]

Psilopoulos D, Galanis P, Goulas S, Papanikolaou IS, Elefsiniotis I, Liatsos C, et al. Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial. European Journal of Gastroenterology and Hepatology. 2005;17(10):1111–1117. [PubMed: 16148558]

Pugh RN, Murray-Lyon I, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery. 1973;60(8):646–649. [PubMed: 4541913]

Qamar AA, Grace N, Groszmann R, Garcia-Tsao G, Bosch J, Burroughs A, et al. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology. 2008;47(1):153–159. [PubMed: 18161700]

Rahimi RS, Singal AG, Cuthbert JA, Rockey DC. Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA Internal Medicine. 2014;174(11):1727–1733. [PMC free article: PMC5609454] [PubMed: 25243839]

Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. American Journal of Gastroenterology. 2002;97(10):2614–2618. [PubMed: 12385448]

Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Medicine. 2012;38(3):368–383. [PubMed: 22323076]

Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt P, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology. 2005;58(10):982–990. [PubMed: 16168343]

Rizzo L, Calvaruso V, Cacopardo B, Alessi N, Attanasio M, Petta S, et al. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. American Journal of Gastroenterology. 2011;106(12):2112–2120. [PubMed: 21971536]

Robic MA, Procopet B, Metivier S, Peron JM, Selves J, Vinel JP, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. Journal of Hepatology. 2011;55(5):1017–1024. [PubMed: 21354450]

Rolachon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology. 1995;22(4 Pt.1):1171–1174. [PubMed: 7557868]

Rossi-Fanelli F, Cangiano C, Capocaccia L, Cascino A, Ceci F, Muscaritoli M, et al. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences. Gut. 1986;27(Suppl.1):111–115. [PMC free article: PMC1434629] [PubMed: 3539709]

Rossi-Fanelli F, Cangiano C, Cascino A, Merli M, Riggio O, Stortoni M. Branched-chain amino acids in the treatment of severe hepatic encephalopathy. In: Capocaccia L, Fischer JE, Rossi-Fanelli F, editors. Hepatic encephalopathy in chronic liver failure. New York: Plenum Press; 1984. pp. 335–344.

Rossi-Fanelli F, Riggio O, Cangiano C, Cascino A, De Conciliis D, Merli M, et al. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study. Digestive Diseases and Sciences. 1982;27(10):929–935. [PubMed: 6749458]

Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. New England Journal of Medicine. 2000;342(23):1701–1707. [PubMed: 10841872]

Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57(4):1651–1653. [PubMed: 23463403]

Saab S, Nieto J, Lewis SK, Runyon BA. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database of Systematic Reviews. 2006;(4) CD004889. [PMC free article: PMC8855742] [PubMed: 17054221] [CrossRef]

Sabat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella M, et al. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding. American Journal of Gastroenterology. 1998;93(12):2457–2462. [PubMed: 9860409]

Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. Journal of Hepatology. 2004;40(6):897–903. [PubMed: 15158328]

Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310–1318. [PMC free article: PMC1954971] [PubMed: 17389705]

Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40(3):629–635. [PubMed: 15349901]

Sanchez-Conde M, Montes-Ramirez ML, Miralles P, Alvarez JMC, Bellon JM, Ramirez M, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. Journal of Viral Hepatitis. 2010;17(4):280–286. [PubMed: 19732322]

Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004;126(4):1005–1014. [PubMed: 15057740]

Santi V, Trevisani F, Gramenzi A, Grignaschi A, Mirici-Cappa F, Del Poggio P, et al. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. Journal of Hepatology. 2010;53(2):291–297. [PubMed: 20483497]

Santos J, Planas R, Pardo A, Durandez R, Cabre E, Morillas R, et al. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. Journal of Hepatology. 2003;39(2):187–192. [PubMed: 12873814]

Sanyal AJ, Gennings C, Reddy KR, Wong F, Kowdley K, Benner K, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124(3):634–641. [PubMed: 12612902]

Sarin SK, Guptan RK, Jain AK, Sundaram KR. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. European Journal of Gastroenterology and Hepatology. 1996;8(4):337–342. [PubMed: 8781902]

Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. New England Journal of Medicine. 1999;340(13):988–993. [PubMed: 10099140]

Sarin SK, Mishra SR, Sharma P, Sharma BC, Kumar A. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: A randomized controlled trial. Hepatology International. 2013;7(1):248–256. [PubMed: 26201639]

Sarin S, Lamba G, Kumar M, Misra A, Murthy N. Randomized trial of propranolol vs endoscopic variceal ligation in the primary prophylaxis of bleeding from high risk varices in cirrhosis: an interim analysis. Hepatology. 1997;26(4 Pt.2):360A.

Schcpka M, Goebel C, Nuernberg D, Willert J, Koch L, Sauerbruch T. Endoscopic banding ligation versus propranolol for the primary prevention of variceal bleeding in cirrhosis: a randomized controlled multicenter trial. Hepatology. 2003;38(4 S1):218.

Schepke M, Kleber G, Nuernberg D, Willert J, Koch L, Veltzke-Schlieker W, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40(1):65–72. [PubMed: 15239087]

Schult A, Eriksson H, Wallerstedt S, Kaczynski J. Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men. Scandinavian Journal of Gastroenterology. 2011;46(6):738–744. [PubMed: 21561285]

Shah HA, Azam Z, Rauf J, Abid S, Hamid S, Jafri W, et al. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial. Journal of Hepatology. 2014;60(4):757–764. [PubMed: 24291366]

Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. American Journal of Gastroenterology. 2013;108(9):1458–1463. [PubMed: 23877348]

Shehab H, Elattar I, Elbaz T, Mohey M, Esmat G. CUFA algorithm: assessment of liver fibrosis using routine laboratory data. Journal of Viral Hepatitis. 2014;21(12):956–964. [PubMed: 24989248]

Sigal SH, Stanca CM, Fernandez J, Arroyo V, Navasa M. Restricted use of albumin for spontaneous bacterial peritonitis. Gut. 2007;56(4):597–599. [PMC free article: PMC1856861] [PubMed: 17369392]

Silva Junior RG, Schmillevitch J, Nascimento MdFA, Miranda ML, Brant PEAC, Schulz PO, et al. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C. Scandinavian Journal of Gastroenterology. 2014;49(8):986–992. [PubMed: 24742130]

Singh B, Saxena PD, Rohtagi V, Kumar V. Comparison of endoscopic variceal ligation and propranolol for the primary prevention of variceal bleeding. Journal, Indian Academy of Clinical Medicine. 2012;13(3):214–217.

Singh N, Gayowski T, Yu VL, Wagener MM. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Annals of Internal Medicine. 1995;122(8):595–598. [PubMed: 7887554]

Sirli R, Sporea I, Bota S, Popescu A, Cornianu M. A comparative study of non-invasive methods for fibrosis assessment in chronic HCV infection. Hepatitis Monthly. 2010;10(2):88–94. [PMC free article: PMC3270362] [PubMed: 22312379]

Song IH, Shin JW, Kim IH, Choi J, Lim CY, Kim JW, et al. A prospective randomized trial between the prophylactic endoscopicvariceal ligation and propranolol administration for prevention offirst bleeding in cirrhotic patients with high-risk esophageal varices. Journal of Hepatology. 2000;32(Suppl.2):41.

Sorensen TIA. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial. Hepatology. 1991;14(6):1016–1024. [PubMed: 1959848]

Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology. 1991;100(2):477–481. [PubMed: 1985045]

Spanish Group for the Study of Bacterial Infections in Cirrhosis. Norfloxacin versus ofloxacin in the prophylaxis of infection in cirrhotic patients with gastrointestinal hemorrhage. Journal of Hepatology. 1998;28(Suppl.1):80.

Sporea I, Sirli RL, Deleanu A, Popescu A, Focsa M, Danila M, et al. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall in Der Medizin. 2011;32(Suppl.1):S46–S52. [PubMed: 20603783]

Sporea I, Bota S, Peck-Radosavljevic M, Sirli R, Tanaka H, Iijima H, et al. Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. European Journal of Radiology. 2012;81(12):4112–4118. [PubMed: 23000186]

Sporea I, Sirli R, Popescu A, Bota S, Badea R, Lupsor M, et al. Is it better to use two elastographic methods for liver fibrosis assessment? World Journal of Gastroenterology. 2011;17(33):3824–3829. [PMC free article: PMC3181444] [PubMed: 21987625]

Steadman R, Myers RP, Leggett L, Lorenzetti D, Noseworthy T, Rose S, et al. A health technology assessment of transient elastography in adult liver disease. Canadian Journal of Gastroenterology. 2013;27(3):149–158. [PMC free article: PMC3732152] [PubMed: 23516679]

Stevenson M, Lloyd-Jones M, Morgan MY, Wong R. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. Health Technology Assessment. 2012;16(4):1–174. [PMC free article: PMC4781535] [PubMed: 22333291]

Stibbe KJM, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, et al. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scandinavian Journal of Gastroenterology. 2011;46(7-8):962–972. [PubMed: 21623677]

Strauss E, da Costa MF. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis. Hepato-Gastroenterology. 1998;45(21):900–904. [PubMed: 9684155]

Strauss E, dos Santos WR, Silva EC, Lacet CM, Capacci MLL, Bernardini AP. Treatment of hepatic encephalopathy: A randomizes clinical trial comparing a branched chain enriched amino acid solution to oral neomycin. Nutritional Support Services. 1986;6(7):18–21.

Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, et al. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepato-Gastroenterology. 1992;39(6):542–545. [PubMed: 1483668]

Stroffolini T, Trevisani F, Pinzello G, Brunello F, Tommasini MA, Iavarone M, et al. Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance. Digestive and Liver Disease. 2011;43(11):875–880. [PubMed: 21684821]

Sushma S, Dasarathy S, Tandon RK, Jain S, Gupta S, Bhist MS. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology. 1992;16(1):138–144. [PubMed: 1618465]

Svoboda P, Kantorova I, Ochmann J, Kozumplik L, Marsova J. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices. Surgical Endoscopy. 1999;13(6):580–584. [PubMed: 10347295]

Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Seminars in Liver Disease. 2008;28(1):26–42. [PubMed: 18293275]

Tellez-Avila F, Sifuentes-Osornio J, Barbero-Becerra V, Franco-Guzman A, Ruiz-Cordero R, Alfaro-Lara R, et al. Primary prophylaxis with ciprofloxacin in cirrhotic patients with ascites: a randomized, double blind study. Annals of Hepatology. 2013;13(1):65–74. [PubMed: 24378268]

Terg R, Fassio E, Guevara M, Cartier M, Longo C, Lucero R, et al. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. Journal of Hepatology. 2008;48(5):774–779. [PubMed: 18316137]

Thompson-Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technology Assessment. 2007;11(34):1–206. [PubMed: 17767898]

Thompson-Coon J, Rogers G, Hewson P, Wright D, Anderson R, Jackson S, et al. Surveillance of cirrhosis for hepatocellular carcinoma: a cost utility analysis. British Journal of Cancer. 2008;98(7):1166–1175. [PMC free article: PMC2359641] [PubMed: 18382459]

Thuluvath PJ, Maheshwari A, Jagannath S, Arepally A. A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Digestive Diseases and Sciences. 2005;50(2):407–410. [PubMed: 15745109]

Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. American Journal of Gastroenterology. 2004;99(8):1470–1476. [PubMed: 15307862]

Trevisani F, De Notariis S, Rapaccini G, Farinati F, Benvegnu L, Zoli M, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). American Journal of Gastroenterology. 2002;97(3):734–744. [PubMed: 11922571]

Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini MC, Di Nolfo MA, et al. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. American Journal of Gastroenterology. 2007;102(5):1022–1031. [PubMed: 17313497]

Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnu L, et al. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? American Journal of Gastroenterology. 2007;102(11):2448–2457. [PubMed: 17617210]

Triantos C, Vlachogiannakos J, Armonis A, Saveriadis A, Kougioumtzian A, Leandro G, et al. Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation. Alimentary Pharmacology and Therapeutics. 2005;21(12):1435–1443. [PubMed: 15948810]

Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J, Fontaine H, et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Hepatology. 2011;54(6):1987–1997. [PubMed: 22144108]

Tripathi D, Ferguson J, Kochar N, Leithead JA, Therapondos G, McAvoy NC, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology. 2009;50(3):825–833. [PubMed: 19610055]

Tsochatzis EA, Bosch J, Burroughs A. Liver cirrhosis. The Lancet. 2014;383(9930):1749–1761. [PubMed: 24480518]

Uribe M, Berthier JM, Lewis H, Mata JM, Sierra JG, Garcia-Ramos G, et al. Lactose enemas plus placebo tablets vs. neomycin tablets plus starch enemas in acute portal systemic encephalopathy. A double-blind randomized controlled study. Gastroenterology. 1981;81(1):101–106. [PubMed: 7239110]

Uribe M, Campollo O, Vargas F, Ravelli GP, Mundo F, Zapata L, et al. Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial. Hepatology. 1987;7(4):639–643. [PubMed: 3301614]

Van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Statistics in Medicine. 2002;21(4):589–624. [PubMed: 11836738]

Van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-analysis. Statistics in Medicine. 1993;12(24):2273–2284. [PubMed: 7907813]

Vilstrup H, Gluud C, Hardt F, Kristensen M, Kohler O, Melgaard B, et al. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. Journal of Hepatology. 1990;10(3):291–296. [PubMed: 2195106]

Wahren J, Denis J, Desurmont P, Eriksson LS, Escoffier JM, Gauthier AP, et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology. 1983;3(4):475–480. [PubMed: 6345330]

Wang JH, Chuah SK, Lu SN, Hung CH, Kuo CM, Tai WC, et al. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis. Liver International. 2014;34(9):1340–1348. [PubMed: 24620731]

Wong VW-S, Vergniol J, Wong GL-H, Foucher J, Chan AWH, Chermak F, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. American Journal of Gastroenterology. 2012;107(12):1862–1871. [PubMed: 23032979]

Wong VW-S, Vergniol J, Wong GL-H, Foucher J, Chan HLY, Le Bail B, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454–462. [PubMed: 20101745]

Yamada H, Ebara M, Yamaguchi T, Okabe S, Fukuda H, Yoshikawa M, et al. A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 cases. Journal of Hepatology. 2006;44(1):68–75. [PubMed: 16271795]

Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare sents: a meta-analysis. Journal of Gastroenterology and Hepatology. 2010;25(11):1718–1725. [PubMed: 21039832]

Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Digestive and Liver Disease. 2008;40(5):371–378. [PubMed: 18083083]

Yoneda M, Suzuki K, Kato S, Fujita K, Nozaki Y, Hosono K, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology. 2010;256(2):640–647. [PubMed: 20529989]

Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. Journal of Hepatology. 2012;56(1):55–62. [PubMed: 21781944]